Related Experiment Videos

Neuropsychological approaches to treatment policy issues in phenylketonuria

P Griffiths1

  • 1Department of Psychology, University of Stirling, Scotland, UK. pvg1@stir.ac.uk

Insights

Continuing phenylketonuria (PKU) dietary management until age 10 protects cognitive functions like memory and motor skills. However, elevated phenylalanine levels above 900 mumol/l may still impact executive functions later in life.

Area of Science:

  • Neuropsychology
  • Metabolic Disorders
  • Pediatrics

Background:

  • Phenylketonuria (PKU) is a metabolic disorder requiring lifelong dietary management.
  • Early cessation of dietary treatment for PKU has been linked to adverse cognitive outcomes.

Purpose of the Study:

  • To evaluate the impact of dietary cessation age and phenylalanine (Phe) levels on neurocognitive outcomes in PKU patients.
  • To assess the protective effects of continued diet on perception, memory, motor skills, and executive functions.

Main Methods:

  • Review of existing neuropsychological research on PKU treatment factors.
  • Analysis of phenylalanine concentrations and their correlation with cognitive performance across different age groups.

Main Results:

  • Dietary cessation before age 10 may be detrimental.
  • Maintaining Phe levels below 1200 mumol/l after age 10 offers protection for perception, memory, and motor skills.
  • Phe levels between 360-600 mumol/l pose a risk to executive skills in preschoolers, with diminishing risk in primary school.
  • Levels above 900 mumol/l in adolescence/adulthood may adversely affect executive abilities, with reversibility uncertain.

Conclusions:

  • Current neuropsychological evidence, though limited, supports existing British and German recommendations for dietary control in PKU.
  • Further research is needed to determine the reversibility of executive function deficits in adult PKU patients with high Phe levels.
Abstract

Related Concept Videos